nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers
|
Martin, Paul D. |
|
2003 |
25 |
10 |
p. 2553-2563 11 p. |
artikel |
2 |
A medicare Rx benefit: So close and yet so far
|
Coons, Stephen Joel |
|
2003 |
25 |
10 |
p. 2610-2613 4 p. |
artikel |
3 |
An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis
|
Weinberg, Jeffrey M. |
|
2003 |
25 |
10 |
p. 2487-2505 19 p. |
artikel |
4 |
A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma
|
Kuna, Piotr |
|
2003 |
25 |
10 |
p. 2634- 1 p. |
artikel |
5 |
A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fracture
|
Christensen, Palle Mark |
|
2003 |
25 |
10 |
p. 2575-2585 11 p. |
artikel |
6 |
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans
|
Leonardi, Andrea |
|
2003 |
25 |
10 |
p. 2539-2552 14 p. |
artikel |
7 |
Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands
|
Bos, Jasper M. |
|
2003 |
25 |
10 |
p. 2614-2630 17 p. |
artikel |
8 |
Letter to the editor
|
Bolaman, Zahit |
|
2003 |
25 |
10 |
p. 2631-2633 3 p. |
artikel |
9 |
Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine
|
Pappagallo, Marco |
|
2003 |
25 |
10 |
p. 2506-2538 33 p. |
artikel |
10 |
Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin
|
Gretler, Daniel D. |
|
2003 |
25 |
10 |
p. 2564-2574 11 p. |
artikel |
11 |
Tolerability and effects on quality of life of twice-daily extended-release carbamazepine in adults with seizure disorders: An open-label, 12- to 36-month continuation study
|
Edward Hogan, R |
|
2003 |
25 |
10 |
p. 2586-2596 11 p. |
artikel |
12 |
Use of gabapentin for postherpetic neuralgia: Results of two randomized, placebo-controlled studies
|
Stacey, Brett R. |
|
2003 |
25 |
10 |
p. 2597-2608 12 p. |
artikel |